Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 3, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

6.6K

Development of replication-defective herpes simplex virus vectors.

D Krisky1, P Marconi, W F Goins

  • 1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Methods in Molecular Medicine
|February 5, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors.

Journal of gene therapy·2018
Same author

Effects of herpes simplex virus vectors encoding poreless TRPV1 or protein phosphatase 1α in a rat cystitis model induced by hydrogen peroxide.

Gene therapy·2017
Same author

Gene therapy-from small beginnings to where we are now.

Gene therapy·2017
Same author

MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats.

Gene therapy·2017
Same author

Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.

Gene therapy·2016
Same author

Moving toward a gene therapy for Huntington's disease.

Gene therapy·2015
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Developing novel gene therapy vectors is crucial for treating central nervous system (CNS) diseases. New strategies are needed to effectively deliver therapeutic genes to non-dividing neurons for improved genetic therapies.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Many nervous system diseases stem from genetic defects.
  • Genetic therapies aim to correct these defects via gene transfer.
  • Current retroviral vectors are unsuitable for non-dividing central nervous system (CNS) neurons.

Purpose of the Study:

  • To address the limitations of current gene therapy vectors for CNS disorders.
  • To outline requirements for novel vectors capable of treating CNS diseases.

Main Methods:

  • Review of existing gene therapy approaches.
  • Identification of challenges in delivering genes to the CNS.
  • Defining criteria for effective CNS gene therapy vectors.

Main Results:

More Related Videos

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

16.1K
Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

19.0K

Related Experiment Videos

Last Updated: May 3, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

6.6K
Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

16.1K
Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

19.0K
  • Retroviral vectors fail in postmitotic CNS neurons.
  • New strategies are required for gene delivery to non-dividing neurons.
  • Novel vectors must efficiently deliver genes, persist long-term, and regulate expression.

Conclusions:

  • Effective gene therapy for CNS diseases necessitates the development of advanced, non-integrating vectors.
  • These vectors must overcome the challenge of targeting terminally differentiated neurons.
  • Future research should focus on creating versatile vectors for diverse therapeutic needs in the CNS.